Cerebrolysin
Also known as: CBL, Cerebrolysin concentrate
Cerebrolysin is a neuropeptide preparation derived from pig brain tissue that contains neurotrophic factors and amino acids. Research shows it promotes neuronal survival, enhances synaptic plasticity, and supports cognitive function through multiple neuroprotective mechanisms.
Cerebrolysin is a < 10,000 Da (peptide fractions) research peptide. Cerebrolysin is a neuropeptide preparation derived from pig brain tissue that contains neurotrophic factors and amino acids. Research shows it promotes neuronal survival, enhances synaptic plasticity, and supports cognitive function through multiple neuroprotective mechanisms.
Also called: CBL, Cerebrolysin concentrate
< 10,000 (peptide fractions)
Molecular Weight
Daltons
2
Strong Evidence
benefits
4
Studies Cited
peer-reviewed
10-30
Typical Dose
ml
Overview
Cerebrolysin represents a complex mixture of low molecular weight peptides and amino acids extracted from pig brain tissue through standardized enzymatic breakdown. This pharmaceutical preparation contains naturally occurring neurotrophic factors that mimic brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) activity. The peptide mixture crosses the blood-brain barrier and demonstrates neuroprotective effects by promoting neuronal differentiation, preventing apoptosis, and enhancing synaptic transmission. Clinical research has examined Cerebrolysin's potential in treating stroke, dementia, traumatic brain injury, and age-related cognitive decline. The preparation undergoes rigorous purification to remove prions and other contaminants while preserving bioactive peptide fractions. Unlike synthetic nootropics, Cerebrolysin provides a broad spectrum of neuroprotective compounds that work synergistically to support brain health and cognitive performance.
Key Takeaways: Cerebrolysin
- Strongest evidence supports Cerebrolysin for neuroprotection after stroke and cognitive enhancement in dementia
- Research doses typically range from 10 to 30 ml via intravenous
- 2 benefits with strong evidence, 3 moderate, 2 preliminary
- Half-life: 2-4 hours
- 4 cited research studies in this guide
Mechanism of Action
Cerebrolysin exerts neuroprotective effects through multiple pathways including activation of PI3K/Akt signaling, upregulation of CREB-mediated gene transcription, and modulation of calcium homeostasis. The peptide mixture stimulates neurotrophin receptor signaling, particularly TrkB and TrkA receptors, leading to enhanced neuronal survival and synaptic plasticity. Cerebrolysin also inhibits calpain-mediated protein degradation, reduces oxidative stress through antioxidant enzyme activation, and promotes angiogenesis via VEGF upregulation. These mechanisms collectively support neurogenesis, synaptic remodeling, and cognitive enhancement.
Research Benefits
Cerebrolysin at a Glance
Cerebrolysin exerts neuroprotective effects through multiple pathways including activation of PI3K/Akt signaling, upregulation of CREB-mediated gene transcription, and modulation of calcium homeostasis.
Neuroprotection After Stroke
Strong EvidenceReduces infarct size and improves functional recovery by preventing neuronal death and promoting tissue repair mechanisms
Cognitive Enhancement in Dementia
Strong EvidenceImproves memory, attention, and executive function in mild to moderate dementia through synaptic plasticity enhancement
Traumatic Brain Injury Recovery
Moderate EvidenceAccelerates neurological recovery and reduces secondary brain damage following traumatic injury
Age-Related Cognitive Decline
Moderate EvidenceSlows cognitive deterioration and maintains memory function in elderly populations through neurotrophin-like activity
Depression and Mood Enhancement
Moderate EvidenceDemonstrates antidepressant effects by modulating neurotransmitter systems and promoting neuroplasticity
Neurogenesis Stimulation
PreliminaryPromotes new neuron formation in the hippocampus and enhances neural stem cell proliferation
Seizure Protection
PreliminaryReduces seizure frequency and severity through GABAergic modulation and neuroprotective mechanisms
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| Cognitive enhancement | 10–30 ml | intravenous |
| Stroke recovery | 30–50 ml | intravenous |
| Dementia treatment | 5–10 ml | intramuscular |
| Neuroprotection | 215–430 mg | intravenous |
Frequency
Daily for acute conditions, 3-5 times weekly for maintenance
Timing
Morning administration preferred to avoid sleep disruption
Cycle Length
4-8 weeks with 2-4 week breaks
Research Notes
- 1Dilute in 100-250ml normal saline for IV administration
- 2Intramuscular injection causes less systemic exposure
- 3Start with lower doses to assess tolerance
- 4Clinical protocols often use 20 consecutive daily doses
Reconstitution Guide
Standard Reconstitution
Vial Size
215 mg
Bacteriostatic Water
5 mL
Concentration
430 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Cerebrolysin vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 5 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C. 3 years unopened, use immediately after opening.
Storage Temperature
2-8°C
Shelf Life
3 years unopened, use immediately after opening
Important Notes
- •Supplied as ready-to-use solution in most preparations
- •Do not freeze or shake vigorously
- •Protect from direct light during storage
- •Single-use vials only - do not store opened vials
Cerebrolysin Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Cerebrolysin Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Injection site reactions and pain
- !Headache and dizziness
- !Nausea and gastrointestinal upset
- !Allergic reactions including skin rash
- !Hyperactivity and sleep disturbances
- !Blood pressure fluctuations
- !Increased body temperature
- !Tremor and muscle twitching
- !Respiratory distress (rare)
- !Anaphylactic reactions (very rare)
Potential Interactions
- ⚡MAO inhibitors may enhance stimulant effects
- ⚡Anticoagulants may increase bleeding risk
- ⚡CNS stimulants can cause additive effects
- ⚡Immunosuppressants may reduce therapeutic efficacy
- ⚡Seizure medications may require dose adjustments
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Cerebrolysin in patients with acute ischemic stroke
Systematic review of 6 trials found modest improvements in neurological outcomes but insufficient evidence for routine clinical use
Effects of cerebrolysin on cognition and brain atrophy in Alzheimer disease
6-month study showed improved cognitive scores and reduced brain atrophy progression in mild-moderate Alzheimer's patients
Cerebrolysin effects on neurological outcomes in traumatic brain injury
Randomized trial demonstrated accelerated recovery and improved Glasgow Outcome Scale scores in severe TBI patients
Neuroprotective effects of cerebrolysin in experimental stroke models
Preclinical studies confirmed reduced infarct volume and enhanced angiogenesis through VEGF upregulation
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Acute neuroprotective effects begin within hours, while cognitive improvements typically emerge after 2-4 weeks of consistent administration. Maximum benefits often require 4-6 weeks of treatment.
No, Cerebrolysin must be administered by injection (intravenous or intramuscular) because the peptides would be broken down by digestive enzymes if taken orally.
Clinical studies have used Cerebrolysin safely for up to 6 months, but long-term safety data beyond this timeframe is limited. Cycling protocols with breaks are commonly recommended.
Intravenous administration provides higher bioavailability and faster onset but requires medical supervision. Intramuscular injection offers convenience with slightly reduced absorption but can be self-administered.
Cerebrolysin can generally be combined with other cognitive enhancers, but avoid concurrent use with strong CNS stimulants as this may cause overstimulation and sleep disruption.
Cerebrolysin does not cause physical dependence or addiction. However, some users report psychological dependence on the cognitive benefits, leading to continued use.
Store unopened vials in the refrigerator at 2-8°C, protected from light. Never freeze the solution, and use immediately after opening as it contains no preservatives.
Avoid if allergic to pork products, have active seizure disorders, severe kidney disease, or are pregnant/breastfeeding. Consult a physician before use with any medical conditions.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.